From: Melanoma risk loci as determinants of melanoma recurrence and survival
Age at pathological diagnosis (years) | Â | Primary tumor thickness (mm) | Â |
---|---|---|---|
Median (Range) | 58 (15–97) | Median (Range) | 0.97 (0.1-33) |
Self-reported ethnicity | Â | AJCC a stage at pathological diagnosis | |
Ashkenazi Jewish | 204 (22.9%) | I | 566 (63.5%) |
Irish | 95 (10.7%) | II | 150 (16.8%) |
Italian | 46 (5.2%) | III | 150 (16.8%) |
Other non-hispanic white | 511 (57.3%) | IV | 23 (2.6%) |
Other | 35 (3.9%) | Unclassified | 2 (0.2%) |
Gender | Â | Primary tumor ulceration | Â |
Male | 501 (56.2%) | Absent | 684 (76.8%) |
Female | 390 (43.8%) | Present | 158 (17.7%) |
 |  | Unclassified/Unknown | 49 (5.5%) |
Family history of melanoma | Â | Primary tumor mitosis | Â |
No | 727 (81.6%) | Absent | 326 (36.6%) |
Yes | 139 (15.6%) | Present | 479 (53.8%) |
Unknown | 25 (2.8%) | Unclassified/Unknown | 86 (9.6%) |
Sentinel lymph node positive | Â | Primary tumor anatomic site | Â |
No | 774 (86.9%) | Axial | 469 (52.6%) |
Yes | 117 (13.1%) | Extremity | 378 (42.4%) |
 |  | Unclassified/Unknown | 44 (4.9%) |
Status at last follow-up | Â | Primary tumor histological subtype | Â |
Alive, no melanoma | 685 (76.9%) | Superficial spreading melanoma | 470 (52.7%) |
Alive, with melanoma | 31 (3.5%) | Nodular melanoma | 223 (25.0%) |
Alive, status unknown | 28 (3.1%) | Acral lentiginous melanoma | 25 (2.8%) |
Died, no melanoma | 14 (1.6%) | Lentigo maligna melanoma | 24 (2.7%) |
Died, with melanoma | 131 (14.7%) | Desmoplastic melanoma | 31 (3.5%) |
Died, status unknown | 2 (0.2%) | Other melanoma | 37 (4.2%) |
 |  | Unclassified/Unknown | 81 (9.1%) |
Recurrence | Â | Multiple primary melanoma | Â |
No | 639 (71.7%) | No | 745 (83.6%) |
Yes | 252 (28.3%) | Yes | 144 (16.2%) |
 |  | Unknown | 2 (0.2%) |